VINZENZ GRUPPE
     
 

Items where Year is 1997

Up a level
Exportieren als [feed] RSS
Gruppieren nach: Autoren | Typ des Eintrags | No Grouping
Wechseln zu: D | R
Anzahl der Einträge: 9.

D

Dubrey, S W, Bilazarian, S, LaValley, M, Reisinger, J, Skinner, M und Falk, R H (1997) Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. American heart journal, 134 (6). pp. 994-1001. ISSN 0002-8703 Item not available from this repository.

R

Reisinger, J, Dubrey, S W und Falk, R H (1997) Cardiac amyloidosis. Cardiol Rev, 5. pp. 317-325. Item not available from this repository.

Reisinger, J, Dubrey, S W und Falk, R H (1997) Restrictive cardiomyopathy. The New England journal of medicine, 336 (26). 1917; author reply 1917-8. ISSN 0028-4793
[img]
Vorschau

Reisinger, J, Dubrey, S W, Lavalley, M, Skinner, M und Falk, R H (1997) Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. Journal of the American College of Cardiology, 30 (4). pp. 1046-51. ISSN 0735-1097 Item not available from this repository.

Reisinger, J und Falk, R H (1997) Clinical value of a new Doppler index in cardiac amyloidosis. Journal of the American College of Cardiology, 29 (2). pp. 471-2. ISSN 0735-1097 Item not available from this repository.

Reisinger, J und Falk, R H (1997) Pharmacological therapy of atrial fibrillation - an individualized approach. ACC Current Journal Review 6 (5). pp. 28-32. Item not available from this repository.

Reisinger, J, Gattermeier, M und Kühn, P (1997) Images in cardiovascular medicine: complete heart block. Circulation, 96 (4). p. 1364. ISSN 0009-7322 Item not available from this repository.

Reisinger, J., Gatterer, E., Kuehn, P. und Slany, J. (1997) Flecainide versus sotalol for immediate conversion of atrial fibrillation (Abstract). J Am Coll Cardiol, 29. 471A. Item not available from this repository.

Reisinger, J., Mendes, L. A., Dubrey, S. W., Comenzo, R., Vosburgh, E., Sanchorawala, V., Skinner, M. und Falk, R. H. (1997) Cardiac involvement in AL amyloidosis is a marker of cardiac and noncardiac death in patients undergoing treatment with intensive intravenous melphalan therapy (Abstract). Circulation, 96. I-697. Item not available from this repository.

Diese Liste wurde am Thu Oct 18 18:22:09 2018 UTC generiert.